Case 1: Political‚ Legal‚ and Ethical Dilemmas in the Global Pharmaceutical Industry 1. What are the key issues and challenges faced by the global pharmaceutical industry? high cost of research and development 12-15 years and more than $800 million 1 in 10‚000 investigated and tested compounds is approved for patent use 3 out of 10 new‚ approved compounds are successful enough to recover their R&D costs high enough price to cover the cost of product development and cover the cost of products
Free Trademark Intellectual property Copyright
For me as a former worker in the medical field‚ who is coming from the other part of the world‚ the predilection for medicament over usage in the U.S. was always surprising. Therefore‚ I was expecting to see in this video issues about psycho-neurological side effects of overmedicated in somatically ill child. There were several memorable moments which impacted my mind. One of them was Jacob’s story. It was sad to see how the persistent labeling with hyperactivity by preschool teachers took
Premium Bipolar disorder Schizophrenia Antipsychotic
ELI LILLY IN INDIA RETHINKING THE JOINT VENTURE Kishore – 01 STRATEGY Abhay Abhishek Kunal – 05 Anil Kumar Jadli – 11 J.Harish – 25 Khushal Malik – 28 Sharad Singh – 49 PHARMACEUTICAL INDUSTRY – Global Trend • • • • Mainly concentrated in the United States‚ Europe‚ and Japan Developing a drug from discovery to launch took 10 to 12 years. Cost of development of drug is between $500-$800 million. Drugs were strictly controlled by government agencies: o Food and Drug Administration (FDA) – USA‚
Premium Generic drug Pharmaceutical industry Ranbaxy Laboratories
A project report on INTER COMPANY ANALYSIS Analysis of Pharmaceutical Industry in the Indian environment and comparative analysis among Ranbaxy Laboratories Ltd. and Cipla Ltd. Under the guidance of Prof P. Madhavan Visiting Professor‚ IIM Rohtak Undertaken by Ashwani Kumar Atif Aslam Dhiraj Rishiraj Sisodiya Shashi Singh pgp03.016 pgp03.017 pgp03.019 pgp03.054 pgp03.053 This project report is submitted as a partial requirement for the fulfilment of the Business Analysis and Valuation
Premium Financial ratios Financial ratio Generic drug
content Introduction Methods Results 1- Introduction to drug safety 2- The Drug Studies on Safety. 1- Pre-Approval studies 2- Post-Approval studies 3- Post marketing Studies Discussion References Introduction Pharmaceutical companies today like to produce many new drugs‚ but there are several potential risks associate with the production of any new medicine. In addition‚ there is numerous new side effects come from approved drugs. This paper aims to help understand
Premium Pharmacology Pharmaceutical industry Clinical research
of the Indian Pharmaceutical Industry. With the signing of the General Agreement of Trade and Tariff and the World Trade Organization Treaty‚ India agreed to recognize both product and process patents. This made patented drugs with a modified process. Due to this‚ India has developed tremendous competitive edge in the manufacturing bulk drugs and formulations. These abundant opportunities with their challenges are where I see myself making a contribution to the Indian Pharmaceutical Industry and in
Premium Pharmacy Pharmacology Pharmaceutical formulation
‚ 2008; Grabowski et al.‚ 2011) have discussed the advantages and disadvantages of manufacturing authorized and unauthorized generic drugs. This issue is controversial because it involves the interests of a wide range of stakeholders‚ such as pharmaceutical companies‚ governments and the general public. Although there are numerous factors involved‚ opinions on the situation can be divided into four general areas‚ political‚ economic‚ health-related and technological. Those who support manufacture
Premium Generic drug Food and Drug Administration Pharmaceutical industry
qd * Zoloft 100 mg qd * Synthroid 0.25 mg qd * Detrol XL 4 mg qd * Norpace 150 mg bid * Inderal 80 mg bid * Bumex 2 mg qd * Aldactone 100 mg qd * Avapro 300 mg qd * Prinivil 40 mg qd * Glucophage 850 mg bid DESYREL (1) 300 mg bid The active pharmaceutical ingredient in it is trazadone‚ an oral drug available as a regular/extended release tablet to be taken twice daily. STRUCTURE MECHANISM OF ACTION It is a selective serotonin receptor inhibitor that inhibits reuptake of serotonin and causes subsensitivity
Premium Hypertension Pharmaceutical industry Pharmacology
RESUME RAVAL KAVIT HARSIDDHARAY Department of Pharmaceutical Engineering‚IIT-BHU‚Varanasi. Mob no: 08081930031 Email id: raval.kavit.phe11@itbhu.ac.in Objective: To be potential resource to the organization where I can utilize all my skills & knowledge which would help the organization to grow & further enhance my growth profile. It would be my never-ending dedication to maintain the spectrum of integrity‚ honesty& character. Education qualification: degree M.pharm B.pharm Xll X
Premium India Pharmacology Gujarat
…………………………………………………………………………….17 EFAS Matrix Analysis ……………………………………………………………………….. 18 Introduction Global pharmaceuticals grew by 3.6% in 2010 to reach over $733 billion with projections reaching $981 billion by the year 2015 (Pharmaceuticals Industry Profile: Global‚ 2011). Pfizer‚ the world leader in the global pharmaceuticals market‚ controls an impressive 9.4% of the global market share (Pharmaceuticals Industry Profile: Global‚ 2011). Sometimes described as Frankenstein’s Monster‚ Pfizer has been aggressively
Premium Corporate governance Board of directors Pharmaceutical industry